1 Bingham JS.What to do with the patient with recurrent wlvovaginal candidiasis.Sex Transm lnfect.1999,75:225-227.
2 Lanchares JL,Hemandez ML Recurrent vaginal candidiasis changes in etiopathogenical patterns.lnt J Gynaecol Obstet,2000,71:529-35.
3 Nomanbhoy F,Steele C,Yano J,et al.Vaginal and oral epithelial cell anti-Candida activity.infect Immun,2002.70:7081-7088.
4 Fewer J.Vaginal candidosis:epidemiological and etiological factors.lnt J Gynaecol Obstet,2000,7l;521-27.
5 Giraldo P,von Nowaskonski A,Gomes FA,et al.Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent wlvovaginal candidiasis.Obstet Gyneco1,2000.95:413-416.
6 Irving G,Miller D,Robinson A,et al.Psychological factors associated with recurrent vaginal candidiasis:a preliminary study.Sex Transm Infect.1998.74:334-338.
7 Fidel PL Jr,Luo W,Steele C,et al.Analysis of vaginal cell populations during experimental vaginal candidiasis.Infect Immun.1999.67:3135-3140.
8 Spacek J,Jilek P,Buchta V,et al.The serum levels of calcium,magnesium,iron and zinc in patients with recurrent vulvovaginal candidosis during attack remission and in healthy controls Mycoses.2005,48:391-395.
9 O'Connor Ml,Sobel JD.Epidemiology of recurrent wlvovaginal candidiasis:identification and strain differentiation of Candida albicans.J Infect Dis,1986,154:358-363.
10 Consolaro ME,Albertoni TA,Svidzinski AE,et al.Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.Mycopathologia,2005,159:501-507
11 Magliani W,Conti S,Cassone A,et al.New immunotherapeutic strategies to control vaginal candidiasis.Trends Mol Med,2002,8:121-126
12 Richter SS,Galask RP,Messer SA,et al.Antifungal susceptibilities of Candida species causing wlvovaginitis and epidemiology of recurrent cases.J Clin Microbio1,2005.43:2155-2162
13 Deva R,Ciccoli R,Kock L,et al.Involvement of aspirin-sensitive oxylipins in wlvovaginal candidiasis.FEMS Microb Lett,2001,198:37-43.
14 Chong PP,Lee YL,Tan BC,et al.Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia.J Med Microbio1,2003.52:657-666.
15 Fodor E,Dosa E,Nagy A,et al.Karyotyping of Candida al6icans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.Acta Microbiol Immunol Hung,2002,49:59-68.
l6 Fidel PL Jr,Wolf NA,KuKuruga MA.T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery.Infect Immun,1996.64:3793-3799.
17 Nomanbhoy F,Steele C,Yano J,et al.Vaginal and oral epithelial cell anti-Candida activity.infect Immun,2002.70;7081-7088.
18 Carvalho LP,Bacellar O,Neves N,et al.Downregulation of IFN-gamma production in patients with recurrent vaginal candidiasis.J Allergy Clin Immunol,2002,109:102-105.
19 Mendling W,Koldovsky U.Immunological investigations in vaginal mycoses.Mycoses,1996,39:177-183.
20 Fidel PL Jr,Barousse M,Lounev V,et al.Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.Med Mycol,2003,41:97-109.
21 Little CH,Georgiou GM.Marceglia A,et al.Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis,Infect mmun,2000,68:3840-3847.
22 Nawrot U,Grzybek-Hryncewicz K,Zielska U,et al.The study of cell-mediated immune response in recurrent vulvovaginal candidiasis.FEMS Immunol Med Microbiol,2000,29:89-94.
23 Saavedra M,Taylor B,Lukacs N,et al.Local production of chemokines during experimental vaginal candidiesis.Infect Immun,1999,11:5820-5826.
24 Sobel JD,Wieseofeld HC,Martens M,et al.Maintenance fluconamle therapy for recurrent wlvovaginal candidiasis.N Engl J Med,2004,351:876-883.
25 Ringdahl EN.Treatment of recurrent wlvovaginal candidiesis.Am Fam Physician,2000,61:3306-3312,3317.
26 Magliani W,Conti S,Salati A,et al.New strategies for treatment of Candida vaginal infections.Rev Iberoam Mico1.2002,19:144-148.
27 Naves NA,Carvalho LP,Lopes AC,et al.Successful treatment of refractory recurrent vaginal candidiasis with cetitizine plus fluoonazole.J Low Genit Tract Dis,2005,9:167-170.
28 Moraes PS,de Lima Goiaba S,Taketomi EA.Candida albicans allergen immunotherapy in recurrent vaginal candidiesis.J Investig Allergol Clin Immuno1,2000,10:305-309.
29 Van Kessel K,Assefi N,Marrazzo 1,et al.Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis:a systematic review.Obstet Gynecol Surv,2003,58:351-358.
30 Fidel PL Jr.Immunity in vaginal candidiasis.Curr Opin Infect Dis.2005.18:107-111.
31 Magliani W,Conti S,Cassone A,et al.New immunotherapeutic strategies to control vaginal candidiasis.Trends Mol Med,2002,8:121-126. |
